Benzinga | Jan 27, 2022 12:09PM EST

ALX Oncology Granted Orphan Drug Designation For 'Treatment for gastric cancer and gastro-esophageal junction cancer'

https://www.accessdata.fda.gov/scripts/opdlisting/oopd/detailedIndex.cfm?cfgridkey=782220